Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-25 @ 9:49 PM
Study NCT ID:
NCT01127451
Status:
COMPLETED
Last Update Posted:
2022-04-13
First Post:
2010-05-19
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma
Sponsor:
Eisai Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06-22
Start Date Type:
ACTUAL
Primary Completion Date:
2015-04-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-04-07
Completion Date Type:
ACTUAL
First Submit Date:
2010-05-19
First Submit QC Date:
None
Study First Post Date:
2010-05-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-01-31
Results First Submit QC Date:
None
Results First Post Date:
2022-04-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-08-22
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2022-03-18
Last Update Post Date:
2022-04-13
Last Update Post Date Type:
ACTUAL